Want to treat dry eye syndrome more effectively and increase your practice’s turnover? But weary of new technology and the financial outlay? Then read on...
We are excited to be exhibiting at the forthcoming Specialist’s club Successful 'Niche' Contact Lens Practice on Monday 30th September 2019 at the ABDO national resource centre Birmingham.
Pete Downing of Hanson Instruments will again be joining CSO at the 37th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) will take place between 14th – 18th September 2019 in Paris.
Hanson Instruments demonstrate the advanced capabilities of the CSO MS 39 Anterior Segment OCT at ESCRS Congress in Paris
The 37th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) will take place between the 14th – 18th September 2018 in the Paris Expo, Pavilion 7, 1 Place de la Porte de Versailles,75015 Paris.
Hanson Instruments will again be represented on teh CSO stand at the 37th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) will take place between 14th – 18th September 2019 in Paris.
Hanson Instruments, proudly exhibited at The British Contact Lens Association Exhibition (BCLA) 2019. Here are a few photos of us getting set up and ready for the show. We are sure it's going to be a fantastic event and are really excited to be showing off our range of Dry Eye and MGD equipment and tools.
Professor James Wolffsohn of Aston University will be demonstrating the latest diagnostic, screening and treatments available for high street optometry practices in the Exchange Auditorium at the BCLA Clinical Conference and Exhibition on Saturday, 1st June from 10am.
Hanson Instruments appointed as the only authorized distributor to the UK Optometry sector of a major Italian manufacturer’s complete line of screening and treatment products for Dry-Eye & Meibomian Gland Dysfunction.Midlands based manufacturer and supplier Hanson Instruments is excited to announce its appointment as the only authorized distribu
Optometrists now have another test available to them using CSO’s Retimax – the Glaucoma Hemifield PERG test. This can detect dysfunctions of the retinal ganglion cells before the irreversible apoptosis process has started.
The MS 39 is a new device for the analysis of the anterior segment of the eye. It provides high resolution OCT images of the anterior chamber, combined with placido disk topography.